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Introduction  
Human papilloma virus is a common virus spread 
among sexually active men and women. The 
implications for women are HPV infections that may 
cause dysplastic changes of the cervix over time. 
Nursing care should be geared toward prevention, with 
vaccination and Pap smears among the two best 
practice modalities. Close monitoring with use of the 
most current algorithms should guide the management 
of HPV lesion surveillance.  
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     Among sexually active men and women, the human papilloma virus (HPV) is one of 
the most common sexually transmitted infections. With more than 200 different 
genotypes of HPV known, there are more than 500,000 cases each year in the United 
States alone (Lowy, 2016). The virus is associated with nearly all cervical cancers, anal 
cancers, vaginal cancers, penile cancers, and head and neck cancers (Jorge & Wright, 
2016). In women, the virus is capable of causing slow cellular changes on the cervix, 
and this dysplasia is graded based on severity (Jorge & Wright, 2016).  
     The statistics related to the prevalence and transmission rate of this virus are 
staggering, and primary healthcare providers must have a solid knowledge base of the 
pathophysiology behind the disease process to better serve their patient population. 
This project will examine the pathophysiology associated with the different stages of 
cervical dysplasia, and to review the nursing implications in managing this disease 
population.  
Transmission, Signs & Symptoms 
Underlying Pathophysiology 
 There are more than 100 types of HPV (Smith & Travis, 
2011). 
 HPV infects the basal layer of the epithelium, and in these 
lesions, the viral HPV DNA is integrated into the human 
genome. These oncogenes can manipulate healthy cells 
by inducing chromosomal abnormalities and blocking 
apoptosis (Jorge & Wright, 2016). 
 Most HPV infections are transient, but cytology changes 
may persist. The patient will generally not experience 
symptoms of the infection (Smith & Travis, 2011). 
 High-risk HPV proteins E6 and E7 are responsible for 
protein degradation, causing chromosomal instability 
and cell proliferation (Orlando et al., 2013). 
 E6 and E7 act as mutagens and promote cell division and 
delayed cell differentiation, leading to hyperproliferative 
lesions (Orlando et al., 2013).  
 Early HPV proteins can increase the number of epidermal 
growth factor receptors, allowing HPV-infected cells to 
ignore antigrowth signals (Orlando et al., 2013). 
 
 Significance of Pathophysiology 
 HPV types 16 & 18 cause 70% of cervical cancers 
(Smith & Travis, 2011). 
 Persistent infections have the highest risk for 
developing high-grade precancerous lesions or 
cervical cancer, and co-infection with more than 1 
HPV serotype increases this risk(Smith & Travis, 
2011). 
 HPV infection cofactor classification (Charlton et 
al., 2014): 
 Environmental/exogenous factors 
(smoking, diet, oral contraceptives) 
 Host factors (endogenous hormones, 
genetics, immune response) 
 Viral factors (HPV type, viral load, viral 
integration) 
 HPV infection is slow progressing. 15% of 
high=grade lesions progress to invasive cervical 
cancer in 5-10 years (Jorge & Wright, 2016). 
Nursing Considerations 
 Vaccination with the HPV Quadrivalent Recombinant 
vaccine is standard of care for all females aged 9-26, 
but is contraindicated in pregnancy (Smith & Travis, 
2011). 
 The counseling approach of younger patients and 
their parents may be different than that of a sexually 
active, more mature population (Sussman et al., 
2015). 
 HPV types 16 & 18 are responsible for most cervical 
lesions  & cancers (Moore et al., 2011). 
 HPV DNA testing with cervical cytology is 
recommended (Nelson et al., 2104). 
 Treatment of persistent HPV: colposcopies, cold 
knife conization, and loop electrosurgical excision 
procedures (LEEP) (Charlton et al., 2014). 
 Excisional procedures cause cervical collagen 
remodeling, and this may lead to an increased risk of 
preterm birth (Miller et al., 2015). 
 Smoking, number of sexual partners, and use of oral 
contraceptives are risk factors (Charlton et al., 
2014). 
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Conclusion 
Figure 2. Correlation of pap test with cross-section of 
cervix (mckinley.illinois.edu, 2016). 
 The virus is spread by direct skin-to-skin contact of the genitals and other skin 
surfaces. Since the virus requires a tissue to tissue interaction, HPV cannot be spread 
by touching inanimate surfaces, such as a toilet seat (Smith & Travis, 2011). 
 Engaging in high-risk sexual behavior increases the risk of HPV transmission. High-
risk behaviors include inconsistent condom use, multiple sex partners, having a new 
partner, or having sex while under the influence of drugs/alcohol (Goyle, Mattocks, & 
Sadler, 2012). 
 Roughly 6 million new cases of HPV are reported yearly worldwide in both men and 
women, with approximately 20 million men and women already infected in the 
United States (Smith & Travis, 2011).  
 Human papillomavirus has a high infectivity rate with up to a 60% chance of 
transmission per sexual contact (Jorge & Wright, 2016).  
 The patient will not usually experience symptoms with cervical changes from the 
high-risk HPV strains, which is why routine Pap smears are important for 
discovering and managing these precancerous lesions (Smith & Travis, 2011). 
